107 related articles for article (PubMed ID: 26614199)
1. New Anyplex™ II MTB/MDR/XDR kit for detection of resistance mutations in M. tuberculosis cultures.
Causse M; Ruiz P; Gutierrez JB; Vaquero M; Casal M
Int J Tuberc Lung Dis; 2015 Dec; 19(12):1542-6. PubMed ID: 26614199
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis.
Pérez-García F; Ruiz-Serrano MJ; López Roa P; Acosta F; Pérez-Lago L; García-De-Viedma D; Bouza E
J Microbiol Methods; 2017 Aug; 139():74-78. PubMed ID: 28511895
[TBL] [Abstract][Full Text] [Related]
3. Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
Igarashi Y; Chikamatsu K; Aono A; Yi L; Yamada H; Takaki A; Mitarai S
Diagn Microbiol Infect Dis; 2017 Dec; 89(4):276-281. PubMed ID: 28974394
[TBL] [Abstract][Full Text] [Related]
4. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens.
Chumpa N; Kawkitinarong K; Rotcheewaphan S; Sawatpanich A; Petsong S; Tumwasorn S; Suwanpimolkul G
Mol Biol Rep; 2020 Apr; 47(4):2501-2508. PubMed ID: 32124172
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection.
Jin J; Zhang Y; Fan X; Diao N; Shao L; Wang F; Hu P; Wang S; Weng X; Zhang W
Int J Tuberc Lung Dis; 2012 Apr; 16(4):521-6. PubMed ID: 22325117
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
Hillemann D; Rüsch-Gerdes S; Richter E
J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis].
Gui XH; Xu P; Zhao M; Wang LL; Wu J; Li J; Gao Q; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains].
Chikamatsu K; Mizuno K; Aono A; Yamada H; Sugamoto T; Nishiyama H; Mitarai S
Kekkaku; 2011 Jul; 86(7):697-702. PubMed ID: 21922778
[TBL] [Abstract][Full Text] [Related]
10. Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus.
Santos PFGD; Costa ERD; Ramalho DM; Rossetti ML; Barcellos RB; Nunes LS; Esteves LS; Rodenbusch R; Anthony RM; Bergval I; Sengstake S; Viveiros M; Kritski A; Oliveira MM
Mem Inst Oswaldo Cruz; 2017 Jun; 112(6):396-403. PubMed ID: 28591399
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the GenoType MTBDR
Gardee Y; Dreyer AW; Koornhof HJ; Omar SV; da Silva P; Bhyat Z; Ismail NA
J Clin Microbiol; 2017 Mar; 55(3):791-800. PubMed ID: 27974543
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Three Commercial Molecular Assays for Detection of Rifampin and Isoniazid Resistance among Mycobacterium tuberculosis Isolates in a High-HIV-Prevalence Setting.
Strydom K; Ismail F; Matabane MM; Onwuegbuna O; Omar SV; Ismail N
J Clin Microbiol; 2015 Sep; 53(9):3032-4. PubMed ID: 26135869
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of the GenoType MTBDR
Liu Q; Li GL; Chen C; Wang JM; Martinez L; Lu W; Zhu LM
Chin Med J (Engl); 2017 Jul; 130(13):1521-1528. PubMed ID: 28639565
[TBL] [Abstract][Full Text] [Related]
14. Underestimation of the resistance of Mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test.
Jin J; Shen Y; Fan X; Diao N; Wang F; Wang S; Weng X; Zhang W
J Mol Diagn; 2013 Jan; 15(1):44-50. PubMed ID: 23159109
[TBL] [Abstract][Full Text] [Related]
15. Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.
Barnard M; Warren R; Gey Van Pittius N; van Helden P; Bosman M; Streicher E; Coetzee G; O'Brien R
Am J Respir Crit Care Med; 2012 Dec; 186(12):1298-305. PubMed ID: 23087027
[TBL] [Abstract][Full Text] [Related]
16. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.
Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN
Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707
[TBL] [Abstract][Full Text] [Related]
17. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.
Hillemann D; Weizenegger M; Kubica T; Richter E; Niemann S
J Clin Microbiol; 2005 Aug; 43(8):3699-703. PubMed ID: 16081898
[TBL] [Abstract][Full Text] [Related]
18. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.
Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E
Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: phenotypic and genotypic methods.
Miyata M; Pavan FR; Sato DN; Marino LB; Hirata MH; Cardoso RF; de Melo FA; Zanelli CF; Leite CQ
Biomed Pharmacother; 2011 Sep; 65(6):456-9. PubMed ID: 21880463
[TBL] [Abstract][Full Text] [Related]
20. Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania.
Bang D; Andersen SR; Vasiliauskienė E; Rasmussen EM
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):377-381. PubMed ID: 27641092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
